• Filing Date: 2020-08-03
  • Form Type: 10-Q
  • Description: Quarterly report
v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents $ 1,933 $ 1,075
Restricted cash and cash equivalents 496 461
Accounts receivable, net 1,887 776
Inventory 677 302
Notes receivable, current portion 170 0
Other current assets, net 311 175
Current assets of discontinued operations 4 7,441
Total current assets 5,478 10,230
LONG-TERM ASSETS    
Property and equipment, net 578 442
Right-of-use lease assets, net 330 283
Goodwill 6,336 6,336
Intangible assets, net 7,751 8,244
Notes receivable, long-term 2,130 0
Long- term assets of discontinued operations 0 3,457
Total long-term assets 17,125 18,762
Total assets 22,603 28,992
CURRENT LIABILITIES    
Accounts payable and accrued expenses 4,182 3,678
Loans payable, current portion 251 0
Lease liability, short-term 231 148
Contract liabilities 902 749
Current liabilities of discontinued operations 104 5,757
Total current liabilities 5,670 10,332
LONG-TERM LIABILITIES    
Notes payable subject to exchange for stock [1] 14,636 0
Notes payable, long-term 5,367 20,409
Loans payable, long-term 623 0
Lease liability, long term 114 161
Contract liabilities, long term 802 775
Other long-term liabilities 10 10
Long term liabilities held for sale and discontinued operations 21 536
Total long-term liabilities 21,573 21,891
Total liabilities 27,243 32,223
Series A Cumulative Convertible Redeemable Preferred stock, $0.0001 par value, 505,000 shares authorized and 502,327 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 6,222 5,804
Commitment and Contingencies
STOCKHOLDERS' (DEFICIT) EQUITY    
Common stock, $0.0001 par value, 100,000,000 and 30,000,000 shares authorized, 22,942,546 and 21,595,653 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 2 2
Preferred stock, $0.0001 par value, 2,000,000 authorized, 505,000 shares designated as Series A and 240,861 shares designated as Series B as of June 30, 2020 and December 31, 2019, respectively 0 0
Series B Cumulative Convertible Preferred stock, $0.0001 par value, 240,861 shares authorized, issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 0 0
Additional paid-in capital 22,180 19,371
Accumulated deficit (33,044) (28,408)
Total stockholders' (deficit) equity (10,862) (9,035)
Total liabilities and stockholders' (deficit) equity $ 22,603 $ 28,992
[1] As of June 30, 2020, these notes were the subject to an agreement providing for them to be exchanged for common stock as described in Note 7.